Insider · CIK 0001600049
Gary Bridger
Files at XFOR (X4 Pharmaceuticals, Inc). First filing -, latest -.
In brief
Gary Bridger files SEC Form 4 as director at XFOR (X4 Pharmaceuticals, Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gary Bridger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +110,000 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Jun 9, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Common Stock | +1,500 | $0.00 | $0 | 4,722 | Jun 10, 2025 |
Questions about Gary Bridger
Answered from the filings on this page, as of the latest one.
Is Gary Bridger buying or selling?
Gary Bridger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gary Bridger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gary Bridger has 0.
Where does Gary Bridger file Form 4?
Gary Bridger has filed Form 4 at XFOR (X4 Pharmaceuticals, Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.